CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...